The FLT3 internal tandem duplication (ITD) is the most clinically significant FLT3 mutation, and patients with FLT3-ITD mutated AML have increased rates of disease relapse, and inferior overall survival [7]. Here, FLT3 is linked to acute myeloid leukemia.